List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 20 studies with search of: Open Studies | "Jejunal Neoplasms"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: veliparib;   Other: laboratory biomarker analysis;   Other: pharmacological study
2 Unknown † High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: methotrexate;   Drug: prednisolone;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: biopsy;   Procedure: peripheral blood stem cell transplantation
3 Unknown † Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Drug: vorinostat;   Genetic: DNA analysis;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Other: laboratory biomarker analysis
4 Recruiting MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: Akt inhibitor MK2206;   Other: laboratory biomarker analysis;   Other: pharmacological study
5 Unknown † Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Procedure: radionuclide imaging;   Radiation: indium In 111-labeled autologous peripheral blood mononuclear cells;   Radiation: indium In 111-labeled autologous polymorphonuclear leukocytes
6 Recruiting Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Conditions: Non-melanomatous Skin Cancer;   Pancreatic Cancer;   Small Intestine Cancer;   Testicular Germ Cell Tumor
Interventions: Genetic: in situ hybridization;   Genetic: protein expression analysis;   Other: immunologic technique
7 Unknown † Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer
Interventions: Biological: autologous immunoglobulin idiotype-KLH conjugate vaccine;   Biological: sargramostim;   Drug: methotrexate;   Drug: thiotepa;   Radiation: radiation therapy
8 Unknown † 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: gemcitabine hydrochloride;   Drug: triapine
9 Unknown † Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Secondary Myelofibrosis;   Small Intestine Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiation
10 Recruiting Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Condition: Small Intestine Cancer
Interventions: Drug: capecitabine;   Drug: irinotecan hydrochloride;   Drug: oxaliplatin
11 Recruiting GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Gastrointestinal Stromal Tumor;   Kidney Cancer;   Malignant Neoplasm of Conjunctiva;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: Hedgehog antagonist GDC-0449;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097
12 Recruiting Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Liver Cancer;   Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: dasatinib;   Other: pharmacological study
13 Unknown † Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8
14 Recruiting Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer;   Pancreatic Cancer;   Periampullary Adenocarcinoma;   Small Intestine Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: laboratory biomarker analysis
15 Unknown † Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Biological: alemtuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisolone;   Drug: vincristine sulfate;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
16 Recruiting Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Conditions: Colorectal Cancer;   Esophageal Cancer;   Gastric Cancer;   Small Bowel Cancer;   Pancreatic Cancer
Intervention:
17 Recruiting RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Colorectal Cancer;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: capecitabine;   Drug: gamma-secretase inhibitor RO4929097;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study
18 Unknown † FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 2'-F-ara-deoxyuridine;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: high performance liquid chromatography;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: pharmacological study;   Procedure: positron emission tomography
19 Recruiting Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Unknown † Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neutropenia;   Psychosocial Effects of Cancer and Its Treatment;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: amoxicillin-clavulanate potassium;   Drug: ciprofloxacin;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services